Vir Biotechnology, Inc. — Director's Dealing 2020

Dec 11, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vir Biotechnology, Inc. (VIR)
CIK: 0001706431
Period of Report: 2020-12-09

Reporting Person: Hatfield Jeffrey S. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-09	Stock Option (Right to Buy)	$29.43	A	46500	Acquired	2030-12-08	Common Stock (46500)	Direct

Footnotes

F1: 1/3 of the shares subject to the stock option vest and become exercisable on December 9, 2021, and the remaining shares vest in 24 equal monthly installments thereafter.